A Study to Evaluate the Safety and Efficacy of Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (SOLSTICE-HCM)
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 500 participants.
Also called NCT07940777
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 500 participants
- Sponsor
- Registry
-
NCT07940777
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07940777. Randomized; quadruple masking; primary purpose treatment. Start 2026-12-29 (anticipated); primary completion 2029-07-21 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Evaluate the Safety and Efficacy of Mavacamten in Adults With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy (SOLSTICE-HCM)
- Acronym
- SOLSTICE-HCM
- Condition
- Non-obstructive Hypertrophic Cardiomyopathy
- Intervention (Drug)
- Mavacamten
- Intervention (Other)
- Placebo
- Lead sponsor
- Bristol-Myers Squibb
Record details
- Record id
cardio:ct-nct07940777- Content hash
f36bba4df4b3007451cd67c7a71dbd30b75ab02231f9974ecfee5c6f099de2b0